Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...

Keeping momentum going, Oura announced a new ceramic smart ring lineup today, along with multi-ring support in the app, as ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...

The report claims that inaccurate readings from the G7 device have resulted in hospitalizations and deaths among diabetic patients. According to Hunterbrook, an FDA inspection revealed DexCom made an ...

BTIG analysts said Senseonics is doubling down on its belief an inflection point in patient demand is imminent, but the company will need a large sales force to win market share.

From better sleep to less stress, doctors share their thoughts on how different technology can help support our well-being.

Earlier this year, Purdue changed its pharmacy benefits manager to AffirmedRx. Now, some employees will have to pay thousands ...

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them.

The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.

DexCom (DXCM) stock declines after a short report, yet analysts from TD Cowen and Baird stay bullish on the company's ...